End-Stage Disease

In this installment of In Practice, Stephen J. Forman, MD, director of the T Cell Therapeutics Research Laboratory in the Cellular Immunotherapy Center at City of Hope Comprehensive Cancer Center, discusses how a combination of treatment strategies can help improve the overall effectiveness of chimeric antigen receptor T-cell therapies.